Image credit: CDC

Cannabis Companies Brace for Coronavirus Impact

Amid the COVID-19 pandemic, a dilemma has hit the nascent industry: to close or not to close? We’re keeping track of how companies, and regulators, are reacting.

Business
Regulation

National Academies’ Cannabis Committee Convenes Again

The second meeting of the Committee on the Public Health Consequences of Changes in the Cannabis Policy Landscape is underway this week. Here’s what happened on day one.